Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.59B 4.18B 532M 459M 431M 393M 738M 50.89B 748M 5.05B 1.98B 25.49B 2B 1.95B 84.81B P/E 2026 *
7.89x
P/E 2027 * 7x
Enterprise Value 3.59B 4.18B 532M 459M 431M 393M 738M 50.89B 748M 5.05B 1.98B 25.49B 2B 1.95B 84.81B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.47x
Free-Float
45.7%
Yield 2026 *
5.71%
Yield 2027 * 6.43%
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-0.92%
1 week-4.01%
Current month-8.24%
1 month-9.27%
3 months-13.40%
6 months-26.42%
Current year-26.76%
1 week 3.16
Extreme 3.165
3.46
1 month 3.16
Extreme 3.165
3.61
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.45
3 years 3.07
Extreme 3.07
7.03
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 2025-06-03
Comptroller/Controller/Auditor 48 2025-06-03
Corporate Secretary 37 2026-07-08
Director TitleAgeSince
Director/Board Member 67 2011-02-09
Director/Board Member 69 2018-06-11
Director/Board Member 82 2018-06-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-4.01%-40.07%-49.92% 532M
-0.46%-2.72%-11.01%-6.51% 13.18B
-0.16%-2.78%-32.52%-58.08% 4.97B
-0.81%-4.74%+2.32%-1.96% 4.88B
+0.29%+0.71%+7.12%-27.92% 4.22B
-0.03%-2.82%-18.37%+0.19% 3.57B
+0.20%-1.73%-5.07%+11.71% 3.4B
-1.06%-6.33%-8.56%-10.25% 3.32B
+1.19%+1.45%-12.60%-15.66% 2.52B
0.00%+10.60%+3.45%-10.61% 1.81B
Average -0.18%-0.65%-11.53%-16.90% 4.24B
Weighted average by Cap. -0.24%-1.34%-9.99%-13.69%

Financials

2026 *2027 *
Net sales 6.98B 8.13B 1.04B 894M 839M 764M 1.44B 99.03B 1.46B 9.83B 3.85B 49.61B 3.89B 3.8B 165B 7.56B 8.8B 1.12B 969M 909M 828M 1.56B 107B 1.58B 10.65B 4.17B 53.74B 4.21B 4.12B 179B
Net income 454M 529M 67.42M 58.21M 54.61M 49.74M 93.52M 6.45B 94.82M 640M 251M 3.23B 253M 248M 10.74B 514M 598M 76.17M 65.76M 61.69M 56.19M 106M 7.28B 107M 723M 283M 3.65B 286M 280M 12.14B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
26-08-18 HK$3.230 -0.92% 1,313,000
26-08-17 HK$3.260 -0.61% 511,000
26-08-14 HK$3.280 -1.35% 857,288
26-08-13 HK$3.325 -3.06% 1,839,000
26-08-12 HK$3.430 +1.93% 1,394,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.801CNY
Average target price
4.601CNY
Spread / Average Target
+64.25%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock